In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 76 for your search:
Cancer Type/Condition:  malignant testicular germ cell tumor
Stage/Subtype:  malignant testicular germ cell tumor
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 18 to 50
Sponsor: Other
Protocol IDs: TASTY-01, NL38757.042.11, NCT01641172
2.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 to 60
Sponsor: Other
Protocol IDs: 160/10, NCT01206270
3.

Phase: Phase III
Type: Treatment
Status: Active
Age: Over 16
Sponsor: Other
Protocol IDs: CDR0000416124, FRE-FNCLCC-GETUG-13/0206, EU-20502, NCT00104676
4.

Phase: Phase III
Type: Diagnostic
Status: Active
Age: 19 to 90
Sponsor: Other
Protocol IDs: R05-0076, NCT00207298
5.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 50
Sponsor: Other
Protocol IDs: BARTS-TE3, EU-20608, ISRCTN08648791, NCT00324298
6.

Phase: Phase III
Type: Diagnostic
Status: Active
Age: 16 and over
Sponsor: Other
Protocol IDs: MRC-NCRI-TRISST-TE24, MRC-NCRI-TRISST-TE24, EU-20771, ISRCTN65987321, NCT00589537
7.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 2 to 21
Sponsor: NCI
Protocol IDs: SCUSF-0703, MCC-0703, SCUSF 0703, NCT01132547
8.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 1 to 18
Sponsor: NCI, Other
Protocol IDs: CDR0000588655, COG-ACCL0431, ACCL0431, NCT00716976
9.

Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: VRAM M-20070240, NCT00647569
10.

Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 25387, 1 R01 HL95109-01, NCT00876915
11.

Phase: Phase III
Type: Health services research, Supportive care
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: CDR0000667367, RMH-CCR3086, EUDRACT-2008-002152-26, EU-21010, MREC-08/H0903/40, NCT01087268
12.

Phase: Phase III
Type: Educational/Counseling/Training, Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: UHN REB 09-0855-C, CIHR, NCT01506492
13.

Phase: Phase III
Type: Treatment
Status: Active
Age: 16 and over
Sponsor: Other
Protocol IDs: ICR-CTSU/2008/10019, ISRCTN37875250, 2008-006295-29, 09/H1102/86, CRUK/09/011, NCT01726374
14.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: Under 75
Sponsor: NCI, Other
Protocol IDs: 1825.00, NCI-2010-00230, P01CA078902, FHCRC-1825.00, 5605, SUPERGEN-FHCRC-1825.00, NCT00096161
15.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 16 to 60
Sponsor: Other
Protocol IDs: CDR0000572096, USCTU-UR1002-GEM-TIP, EU-20769, EUDRACT-2004-004804-19, UR1002-Gem-TIP, NCT00551122
16.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: BBI608-201, NCT01325441
17.

Phase: Phase II
Type: Treatment
Status: Active
Age: 16 and over
Sponsor: Other
Protocol IDs: GIP-TG, NCT00127049
18.

Phase: Phase II
Type: Treatment
Status: Active
Age: 16 and over
Sponsor: Other
Protocol IDs: MRC-TE23, EU-205107, ISRCTN53643604, EUDRACT-2004-000405-22, NCT00301782
19.

Phase: Phase II
Type: Treatment
Status: Active
Age: 10 to 69
Sponsor: Other
Protocol IDs: 2006LS032, UMN-MT2005-21, UMN-0608M90586, UMN-2006LS032, NCT00432094
20.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 40
Sponsor: Other
Protocol IDs: CRCA-CCTC-ACCELERATED-BEP, CCTC-ACCELERATED-BEP, EUDRACT-2004-000847-79, EU-20713, NCT00453232
21.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 07-044, MSKCC-07044, NCT00470366
22.

Phase: Phase II
Type: Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: 2007LS072, UMN-MT2007-07, 0707M11845, UMN-2007LS072, NCT00617929
23.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: 12602, PL/ 183/UR/CEBK/04/08, EudraCT 2007-007599-40, NCT00772694
24.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 08 GENH 06, NCT00864318
25.

Phase: Phase II
Type: Treatment
Status: Active
Age: 6 months to 20 years
Sponsor: Other
Protocol IDs: CSET 2008/1378, NCT00918320
1     
New Search